Long-term Cognitive, Neuropsychiatric and Functional Outcomes in Adults Who Have Received Chimeric Antigen-Receptor T-Cell (CAR-T) Therapy for Aggressive Lymphoma at Stanford

Part of paid clinical trials in San Francisco, California.

Sponsor
Stanford University
Study ID
NCT05416554
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Non Hodgkin Lymphoma

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Neuropsychological testing — BEHAVIORAL
    Upon completion of the consent, the subject will be booked into an available 90 minute in-person or remote neuropsychological testing

Study Details

This study aims to assess the feasibility of performing neuropsychological testing to measure the cognitive performance of individuals following Axicabtagene ciloleucel CAR-T therapy at Stanford.

Key Dates

Start date
Dec 31, 2025
Status verified
Feb 2025
Primary completion
Dec 31, 2026
Completion
Dec 31, 2027

Study Design

Enrollment
20 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE

Arms

  • Other: Neuropsychological testing
    Participants will take neuropsychological testing in-person or via telehealth video

Primary Outcome Measure

Number of patients who complete neuropsychological testing in the post-CAR-T adult population [ Time Frame: 6 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Stanford Cancer CenterSan FranciscoCalifornia94305
Michelle Monje, MD, PhD (SUB_INVESTIGATOR)
Gayle Deutsch, PhD, ABPP (SUB_INVESTIGATOR)
Matthew J Frank, MD, PhD (SUB_INVESTIGATOR)
Sheila Lahijani, MD (SUB_INVESTIGATOR)
Tracy P Murray, MSN, RN, AGACNP-BC (SUB_INVESTIGATOR)

Find similar trials in San Francisco, CA

By research site
Stanford Cancer Center· San Francisco, CA

Related Studies